SII
Ramaphosa lauds Serum Institute funding for African health workforce
Johannesburg, Jul 27 (PTI) South African President Cyril Ramaphosa, in his capacity as African Union (AU) COVID-19 Champion, has lauded the Serum Institute of India (SII) for its initiative to…
National Regulator approves “Conditional Market Authorization” of two COVID19 Vaccines- Covaxin and Covishield
The National Regulator, Drugs Controller General of India (DCGI), has given nod to market authorization of two COVID19 vaccines, Covaxin and Covishield subject to certain conditions, here today. The Subject…
India Honours Satya Nadella and Sundar Pichai with Padma Awards
Padma Awards - one of the highest civilian Awards of the country, are conferred in three categories, namely, Padma Vibhushan, Padma Bhushan and Padma Shri. The Awards are given in…
COVID-19: Myth vs Facts – Media reports claiming that India has missed Vaccination targets are misleading
In a recently published news article by a reputed international news agency, it has been claimed that India has missed its vaccination target. This is misleading and does not represent…
India allows Serum Institute to enrol 7-11 year olds in Novavax COVID-19 vaccine trial
BENGALURU (Reuters) -India's drug regulator on Tuesday allowed vaccine maker Serum Institute to enrol kids aged 7-11 years for its trial of U.S. drugmaker Novavax's COVID-19 vaccine, as the country…
France includes Covishield in list of approved vaccines for travel to country
Paris [France), July 19 (ANI): France on Monday included Covishield produced by the Serum Institute of India (SII) and developed by AstraZeneca and Oxford University in the list of approved…
No application received for EU authorisation of Covishield, says European Medicines Agency
By Sahil Pandey New Delhi [India], July 16 (ANI): The European Medicines Agency (EMA) said it has not received any application from the COVID-19 vaccine Covishield maker Serum Institute of…
Sputnik V, Astra Zeneca ‘mix & match’ booster dose results expected by July end
By Shalini Bhardwaj New Delhi [India], July 13 (ANI): Russian Direct Investment Fund (RDIF) is expecting to release the results of Sputnik V and Astrazeneca 'mix and match' vaccine by…
RDIF, SII to start production of Sputnik V COVID-19 vaccine in India from September
By Shalini Bhardwaj New Delhi [India], July 13 (ANI): The Russian Direct Investment Fund (RDIF), Russia's sovereign wealth fund, and Serum Institute of India (SII), announced cooperation to produce in…
Novavax’s COVID-19 vaccine ‘Covavax’ to launch in India by September: Sources
New Delhi [India], June 17 (ANI): The Serum Institute of India (SII) hopes to introduce US firm Novavax's Indian version of the COVID-19 vaccine - 'Covavax' by September this year…
Single dose of vaccine produces more immunity in people who recovered from Covid, says AIG study
Hyderabad (Telangana) [India], June 14 (ANI): A single dose of Covishield vaccine given to those who had recovered from the SARS-CoV-2 infection showed these individuals had a stronger immunity to…
Novavax’s vaccine, also produced by SII, found 90 pc effective against COVID-19 variants
By Sahil Pandey New Delhi [India], June 14 (ANI): US Biotechnology company Novavax on Monday announced that its Covid-19 vaccine provides 100 per cent protection against moderate and severe symptoms…
